626 related articles for article (PubMed ID: 33232785)
1. Nutritional and therapeutic approaches for protecting human gut microbiota from psychotropic treatments.
Ait Chait Y; Mottawea W; Tompkins TA; Hammami R
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110182. PubMed ID: 33232785
[TBL] [Abstract][Full Text] [Related]
2. Gut microbes in neurocognitive and mental health disorders.
Halverson T; Alagiakrishnan K
Ann Med; 2020 Dec; 52(8):423-443. PubMed ID: 32772900
[TBL] [Abstract][Full Text] [Related]
3. The Potential Role of Gut Microbiota in Alzheimer's Disease: From Diagnosis to Treatment.
Varesi A; Pierella E; Romeo M; Piccini GB; Alfano C; Bjørklund G; Oppong A; Ricevuti G; Esposito C; Chirumbolo S; Pascale A
Nutrients; 2022 Feb; 14(3):. PubMed ID: 35277027
[TBL] [Abstract][Full Text] [Related]
4. Restoration of dysbiotic human gut microbiome for homeostasis.
Dixit K; Chaudhari D; Dhotre D; Shouche Y; Saroj S
Life Sci; 2021 Aug; 278():119622. PubMed ID: 34015282
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular Diseases of Developmental Origins: Preventive Aspects of Gut Microbiota-Targeted Therapy.
Hsu CN; Hou CY; Hsu WH; Tain YL
Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371800
[TBL] [Abstract][Full Text] [Related]
6. Evidence of the Dysbiotic Effect of Psychotropics on Gut Microbiota and Capacity of Probiotics to Alleviate Related Dysbiosis in a Model of the Human Colon.
Ait Chait Y; Mottawea W; Tompkins TA; Hammami R
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108487
[TBL] [Abstract][Full Text] [Related]
7. Rebuilding the Gut Microbiota Ecosystem.
Gagliardi A; Totino V; Cacciotti F; Iebba V; Neroni B; Bonfiglio G; Trancassini M; Passariello C; Pantanella F; Schippa S
Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30087270
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota dysbiosis and Huntington's disease: Exploring the gut-brain axis and novel microbiota-based interventions.
Sharma G; Biswas SS; Mishra J; Navik U; Kandimalla R; Reddy PH; Bhatti GK; Bhatti JS
Life Sci; 2023 Sep; 328():121882. PubMed ID: 37356750
[TBL] [Abstract][Full Text] [Related]
9. Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment.
Koszewicz M; Jaroch J; Brzecka A; Ejma M; Budrewicz S; Mikhaleva LM; Muresanu C; Schield P; Somasundaram SG; Kirkland CE; Avila-Rodriguez M; Aliev G
Pharmacol Res; 2021 Feb; 164():105277. PubMed ID: 33166735
[TBL] [Abstract][Full Text] [Related]
10. The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options.
Wang Q; Luo Y; Ray Chaudhuri K; Reynolds R; Tan EK; Pettersson S
Brain; 2021 Oct; 144(9):2571-2593. PubMed ID: 33856024
[TBL] [Abstract][Full Text] [Related]
11. Anorexia nervosa and gut microbiome: implications for weight change and novel treatments.
Wei Y; Peng S; Lian C; Kang Q; Chen J
Expert Rev Gastroenterol Hepatol; 2022 Apr; 16(4):321-332. PubMed ID: 35303781
[TBL] [Abstract][Full Text] [Related]
12. The Other Obesity Epidemic-Of Drugs and Bugs.
Sfera A; Osorio C; Diaz EL; Maguire G; Cummings M
Front Endocrinol (Lausanne); 2020; 11():488. PubMed ID: 32849279
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
Vemuri RC; Gundamaraju R; Shinde T; Eri R
Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
[TBL] [Abstract][Full Text] [Related]
14. Gut dysbiosis and age-related neurological diseases; an innovative approach for therapeutic interventions.
Holmes A; Finger C; Morales-Scheihing D; Lee J; McCullough LD
Transl Res; 2020 Dec; 226():39-56. PubMed ID: 32755639
[TBL] [Abstract][Full Text] [Related]
15. Modulation of Gut Microbiota-Brain Axis by Probiotics, Prebiotics, and Diet.
Liu X; Cao S; Zhang X
J Agric Food Chem; 2015 Sep; 63(36):7885-95. PubMed ID: 26306709
[TBL] [Abstract][Full Text] [Related]
16. Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease.
Goyal D; Ali SA; Singh RK
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110112. PubMed ID: 32949638
[TBL] [Abstract][Full Text] [Related]
17. Lessons to Learn from the Gut Microbiota: A Focus on Amyotrophic Lateral Sclerosis.
Calvo AC; Valledor-Martín I; Moreno-Martínez L; Toivonen JM; Osta R
Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627250
[TBL] [Abstract][Full Text] [Related]
18. Microbiota medicine: towards clinical revolution.
Gebrayel P; Nicco C; Al Khodor S; Bilinski J; Caselli E; Comelli EM; Egert M; Giaroni C; Karpinski TM; Loniewski I; Mulak A; Reygner J; Samczuk P; Serino M; Sikora M; Terranegra A; Ufnal M; Villeger R; Pichon C; Konturek P; Edeas M
J Transl Med; 2022 Mar; 20(1):111. PubMed ID: 35255932
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic-induced gut dysbiosis and barrier disruption and the potential protective strategies.
Duan H; Yu L; Tian F; Zhai Q; Fan L; Chen W
Crit Rev Food Sci Nutr; 2022; 62(6):1427-1452. PubMed ID: 33198506
[TBL] [Abstract][Full Text] [Related]
20. Human gut microbiota/microbiome in health and diseases: a review.
Gomaa EZ
Antonie Van Leeuwenhoek; 2020 Dec; 113(12):2019-2040. PubMed ID: 33136284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
